GLI1 and alveolar rhabdomyosarcoma: It has been reported that the Hh signaling molecules, such as Sonic Hh (SHH), protein patched homolog (PTCH), Smoothened (SMO), and GLI, are expressed in 70–90% of ARMS patients (6, 7).